Clinical Impact of the Introduction of Disease-Modifying Treatments for Alzheimer Disease

There is a shift happening in mental health care, with real-world data and holistic evaluations improving patient outcomes and reducing disparities.

Angela Liu, PhD, MPH, speaks about her study that examined mental health care use by Medicare beneficiaries before and after switching from MA to TM.

The FDA believes that data on MRD and complete response can expedite new drug delivery compared with long-term survival indicators.

Experts discuss the clinical and economic burden of idiopathic pulmonary fibrosis (IPF), emerging clinical data, and strategies to improve patient outcomes.

Patients with psychiatric disorders had higher CRC risk but no increase in CRC-specific mortality.

Chronic gastrointestinal disorders are common and costly for employers. Use of a digital digestive care program was associated with reduced health care spending.